Comparative roles of the cell wall and cell membrane in limiting uptake of xenobiotic molecules by Saccharomyces cerevisiae

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 6, 2003, Pages 2012-2014

  Aouida, Mustapha ^a,b   Tounekti, Omar ^b,c   Belhadj, Omrane ^b   Mir, Lluis M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; XENOBIOTIC AGENT;

ARTICLE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL WALL; DRUG CYTOTOXICITY; DRUG UPTAKE; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE; SPHEROPLAST; YEAST; YEAST CELL;

EID: 0038778643     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.6.2012-2014.2003     Document Type: Article

References (15)

1. Barre, F. X., L. M. Mir, Y. Lecluse, and A. Harel-Bellan. 1998. Highly efficient oligonucleotide transfer into intact yeast cells using square-wave pulse electroporation. BioTechniques 25:294-296.
2. Birren, B., E. D. Green, S. Klapholzy, R. M. Myers, and J. Roskams. 1997. Genome analysis, a laboratory manual, vol. 1, p. 26-29. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
3. Dielbandhoesing, S. K., H. Zhang, L. H. Caro, J. M. van der Vaart, F. M. Klis, C. T. Verrips, and S. Brul. 1998. Specific cell wall proteins confer resistance to nisin upon yeast cells. Appl. Environ. Microbiol. 64:4047-4052.
4. Gehl, J., T. Skovsgaard, and L. M. Mir. 1998. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 9:319-325.
5. Jaroszeski, M. J., V. Dang, C. Pottinger, J. Hickey, R. Gilbert, and R. Heller. 2000. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 11:201-208.
6. Mir, L. M., H. Banoun, and C. Paoletti. 1988. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp. Cell Res. 175:15-25.
7. Moore, C. W. 1994. Potentiation of bleomycin cytotoxicity in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 38:1615-1619.
8. Orlowski, S., J. Belehradek, Jr., C. Paoletti, and L. M. Mir. 1988. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem. Pharmacol. 37:4727-4733.
9. 57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrations. Biochem. Biophys. Res. Commun. 173:259-264.
10. Poddevin, B., S. Orlowski, J. Belehradek, Jr., and L. M. Mir. 1991. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmacol. 42(Suppl.):S67-S75.
11. Pron, G., J. Belehradek, Jr., and L. M. Mir. 1993. Identification of a plasma membrane protein that specifically binds bleomycin. Biochem. Biophys. Res. Commun. 194:333-337.
12. Pron, G., J. Belehradek, Jr., S. Orlowski, and L. M. Mir. 1994. Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem. Pharmacol. 48:301-310.
13. Sherman, F., G. R. Fink, and J. B. Hicks. 1986. Methods in yeast genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
14. Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.
15. Winston, F., C. Dollard, and S. L. Ricupero-Hovasse. 1995. Construction of a set of convenient Saccharomyces cerevisiae strains that are isogenic to S288C. Yeast 11:53-55.